Related Experiment Video
Updated: Jun 20, 2026

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification
Published on: November 16, 2016
Polyphosphate and omptins: novel bacterial procoagulant agents
Thomas H Yun1, James H Morrissey
1Biochemistry Department, College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Microbial polyphosphates and omptins significantly impact blood clotting and sepsis. Polyphosphates promote clot formation, while omptins inactivate clot inhibitors, potentially contributing to severe disease.
Area of Science:
- Microbiology
- Hematology
- Pathophysiology
Background:
- Severe sepsis often leads to multiple organ failure, with blood clotting system derangements playing a critical role.
- Microbial factors can significantly influence host hemostasis during infection.
Purpose of the Study:
- To review the roles of microbial polyphosphates and omptins in modulating the blood clotting system.
- To elucidate the mechanisms by which these microbial products affect hemostasis and contribute to disease pathogenesis.
Main Methods:
- Literature review of studies on polyphosphates and omptins in relation to blood clotting.
- Analysis of biochemical and genetic data on microbial modulation of coagulation factors and inhibitors.
Main Results:
- Polyphosphates enhance blood clotting by activating the contact pathway, accelerating factor V activation, and promoting resistant fibrin clots.
- Omptins, outer membrane proteases, inactivate tissue factor pathway inhibitor (TFPI), a key inhibitor of clot initiation.
- Yersinia pestis omptin (Pla) inactivates TFPI more rapidly than it activates plasminogen, suggesting a dual role in plague pathogenesis.
Conclusions:
- Microbial polyphosphates and omptins are significant modulators of hemostasis with implications for sepsis and infectious diseases.
- Omptin activity, particularly Pla in Yersinia pestis, may contribute to the unique pathology of plague through dual effects on clotting and fibrinolysis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Coagulation
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

